PolyPid (PYPD) Scheduled to Post Earnings on Wednesday

PolyPid (NASDAQ:PYPD) will be announcing its earnings results before the market opens on Wednesday, May 8th. Analysts expect PolyPid to post earnings of ($1.96) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

PolyPid (NASDAQ:PYPD) last released its quarterly earnings data on Wednesday, February 14th. The company reported ($3.97) earnings per share (EPS) for the quarter, missing the consensus estimate of ($2.17) by ($1.80). On average, analysts expect PolyPid to post $-4 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

PolyPid Stock Performance

NASDAQ:PYPD opened at $4.94 on Monday. PolyPid has a twelve month low of $3.57 and a twelve month high of $13.23. The company has a debt-to-equity ratio of 2.17, a quick ratio of 0.83 and a current ratio of 0.83. The firm’s fifty day simple moving average is $4.94 and its 200 day simple moving average is $5.04.

Wall Street Analyst Weigh In

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $14.00 target price on shares of PolyPid in a research report on Wednesday, May 1st.

About PolyPid

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions.